Noordegraaf, Anton Vonk
Bogaard, Harm J.
Article History
First Online: 10 March 2016
Competing interests
: A.V.N. declares that he receives lecture fees from Actelion, Bayer, Eli Lilly, GlaxoSmithKline, and Pfizer; is on the industry advisory board for Actelion and Bayer; and is serving on steering committees for Actelion, Bayer, and Pfizer. H.J.B. declares that he receives lecture fees from GlaxoSmithKline and Pfizer.